| Model Number |
DTMB1QQ |
| Medical Device Problem Code |
Premature Discharge of Battery (1057)
|
| Health Effect - Clinical Code |
Insufficient Information (4580)
|
| Date of Event |
04/16/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Continuation of d10: 6935m55, lead implanted: (b)(6) 2016; 5076-52 lead implanted: (b)(6) 2015.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that during use of the cardiac resynchronization therapy defibrillator (crt-d), at a patient device check, it was noted that there was an estimated five months remaining on the battery.A patient family member stated "the last time the patient was seen it was at seven months and that five months had passed." additionally, it was indicated the family member was insinuating that the patients health issues were due to the battery being ¿low¿.The patient family member was informed that the crt-d was being watched and that the device was indeed working as it should.The crt-d remains in use.No further patient complications have been reported as a result of this event.
|
| |
|
Event or Problem Description
|
|
Additional review of the event and/or additional information received shows that there is no information to reasonably suggest that the device in this report may have caused or contributed to a death or serious injury or that the device in this report has malfunctioned.Therefore, this event did not and does not meet the reporting requirements in 21 cfr 803.
|
| |
|
Additional Manufacturer Narrative
|
|
Correction: b5.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|